Antioxidant effects of propofol in human hepatic microsomes: Concentration effects and clinical relevance

British Journal of Anaesthesia

Volumn 81, Issue 4, 1998, Pages 584-589

  Bao, Y P ^a   Williamson, G ^a   Plumb, G W ^a   Lambert, N ^a   Tew, D ^b   Jones, J G ^b   Menon, D K ^b,c  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Anaesthetics i.v; Enzymes; Glutathione; Hepatocytes; Liver; Propofol

Indexed keywords

ANESTHETIC AGENT; BUTYLCRESOL; INTRALIPID; PROPOFOL; TROLOX C;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN HEPG2; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; LIVER MICROSOME; PRIORITY JOURNAL;

EID: 0031668601     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/81.4.584     Document Type: Article

References (37)

1. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischaemia and reperfusion. Journal of Applied Physiology 1991; 71: 1185-1195.
2. Xue D, Slivka A, Buchan AM. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke 1992; 23: 894-899.
3. Haraldseth O, Gronas T, Unsgard G. Quick metabolic recovery after forebrain ischemia in rats treated with the antioxidant U74006F. Stroke 1992; 22: 1188-1192.
4. Hall ED, Pazara KE, Braughler JM. Effects of tirilazad mesylate on postischemic lipid peroxidation and recovery of extracellular ischemia in gerbils. Stroke 1991; 22: 361-366.
5. Natale JE, Schott RJ, Hall Ed, Braughler JM, Dalecy LG. The 21-aminosteroid U74006 reduces systemic lipid peroxidation, improves neurological function, and reduces mortality after cardiopulmonary arrest in dogs. Progress in Clinical and Biological Research 1989; 308: 891-896.
6. Hall ED, Yonkers PA. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 1988; 19: 340-344.
7. Perkins WJ, Milde LN, Milde JH, Michenfelder JD. Pretreatment with U74006F improves neurological outcome following complete cerebral ischemia in dogs. Stroke 1991; 22: 902-909.
8. McIntosh TK, Banbury M, Smith D, Thomas M. The novel 21-aminosteroid U-74006F attenuates cerebral oedema and improves survival after brain injury in the rat. Acta Neurochirugica Supplement (Wien) 1990; 51: 329-330.
9. Hall ED, Yonkers PA, McCall JM, Braughler JM. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. Journal of Neurosurgery 1988; 68: 456-461.
10. Murphy PG, Myers DS, Davies MJ, Davies M, Webster N, Jones JG. The anti-oxidant potential of propofol (2,6-diisopropylphenol). British Journal of Anaesthesia 1992; 68: 613-618.
11. Weir DL, Goodchild CS, Graham DI. Propofol: effects on indices of cerebral ischemia. Journal of Neurosurgical Anesthesiology 1989; 1: 284-289.
12. Young Y, Tisavipat N, Pickard JD, Jones JG, Menon DK. Neuroprotection in experimental temporary focal cerebral ischaemia: propofol versus isoflurane. European Journal of Anaesthesiology 1997; 14: 320-326.
13. Murphy PG, Atkinson R, Columb MO, Myers DS, Day P. Effect of propofol and thiopentone on free radical-induced haemolysis. British Journal of Anaesthesia 1992; 69: 532P-533P.
14. Murphy PG, Bennet JR, Myers DS, Davies MJ, Jones JG. The effect of propofol anaesthesia on free radical-induced lipid peroxidation in rat liver microsomes. European Journal of Anaesthesiology 1993; 10: 261-266.
15. Eriksson O, Pollesello P, Saris NEL. The inhibition of lipid peroxidation in rat liver mitochondria by the general anesthetic propofol. Biochemical Pharmacology 1992; 44: 391-393.
16. Musacchio E, Rizzoli V, Bianchi M, Bindoli A, Galzigna L. Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacological Toxicology 1991; 69: 75-77.
17. Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesthesia and Analgesia 1987; 66: 1256-1263.
18. Green TR, Bennet SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicology Applied Pharmacology 1994; 129: 163-169.
19. Aarts L, van der Hee R, Dekker I, de Jong J, Langmeijer H, Bast A. The widely used anesthetic agent propofol can replace a-tocopherol as an antioxidant FEBS Letters 1995; 357: 83-85.
20. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. Journal of Biological Chemistry 1991; 266: 11632-11639.
21. 2 and antioxidants have opposite effects on activation of NF - B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO Journal 1993; 12:2005-2015.
22. Lambert N. Isolation of microsomes. In: Harris ELY, Angel S, eds. Protein Purification Methods: A Practical Approach. Oxford: IRL Press, 1989; 101-108.
23. Lambert N, Chambers SJ, Plumb GW, Williamson G. Human cytochrome P-450s are pro-oxidants in iron/ascorbate-initiated lipid peroxidation. Free Radical Research 1996; 24: 177-185.
24. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985; 150: 76-85.
25. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods in Enzymology 1978; 30: 302-310.
26. Wills ED. Lipid peroxide formation in microsomes. General considerations. Biochemical Journal 1969; 113: 315-324.
27. Belisario MA, Arena AR, Pecce R, Borgia R, Staiano N, Lorenzo FD. Effect of enzyme inducers on metabolism of 1-nitropyrene in human hepatoma cell line Hep G2. Chemical-Biological Interactions 1991; 78: 253-268.
28. Bao YP, Chambers SJ, Williamson D. Direct separation of hydroperoxy- and hydroxy-phosphatidylcholine derivatives: application to the assay of phospholipid hydroperoxide glutathione peroxidase. Analytical Biochemistry 1995; 224: 395-399.
29. Wendel A. Glutathione peroxidase. Methods in Enzymology 1981; 77: 325-333.
30. Habig W, Jakoby W. Assays for differentiation of glutathione S-transferase. Methods in Enzymology 1981; 77: 398-405.
31. Baker MT, Chadam MV, Ronnenberg WC. Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes. Anesthesia and Analgesia 1993; 76: 817-821.
32. Janicki PK, James MFM, Erskine WAR. Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro. British Journal of Anaesthesia 1992; 68: 311-312.
33. Chen TL, Ueng TH, Chen SH, Lee PH, Fan SZ, Liu CC. Human cytochrome P450 mono-oxygenase system is suppressed by propofol. British Journal of Anaesthesia 1995; 74: 558-562.
34. Stephens NG, Parsons N, Schofield PM, Kelly F, Cheesman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786.
35. Dierickx PJ. The influence of picolines on glutathione transferase activity and subunit composition in human liver derived Hep G2 cells. Biochemical Pharmacology 1994; 48: 1976-1978.
36. Williamson G, DuPont MS, Wanigatunga S, Heaney RK, Musk SRR, Fenwick GR, Rhodes MJC. Induction of glutathione S-transferase activity in Hep G2 cells by extracts of fruits and vegetables. Food Chemistry 1997; 60: 157-160.
37. Bao Y-P, Williamson G. Phosphotipid hydroperoxide glutathione peroxidase, a selenoenzyme, protects against free-radical-mediated damage to Hep G2 cells. In: Packer L, Traber MG, Xin W, eds. Proceedings of the International Symposium on Natural Antioxidants: Molecular Mechanisms and Health Effects. Champaign, Illinois: AOCS Press 1996; 661-664.